What CryoDAO does

CryoDAO is a decentralized autonomous organization (DAO) registered as a non-profit association in Basel, Switzerland, that funds high-impact cryopreservation, biostasis, and cryobiology research through token-based community governance. The organization operates within the decentralized science (DeSci) ecosystem, with holders of the CRYO governance token proposing and voting on research funding allocations via Snapshot and on-chain voting. Its treasury exceeds $5 million, its community spans 6,000+ members across Discord and Twitter/X, and its CRYO token trades on Uniswap (Ethereum mainnet) and Aerodrome (Base chain).

The organization's core products are the CRYO governance token and the IP-NFT framework for tokenizing and community-governing research intellectual property. To date CryoDAO has funded nine research projects including CRYORAT ($900K for high-subzero preservation and revival of a rat, led by Advanced Neural Biosciences), Live Births from Vitrified Ovaries ($350K with Gaia Life and NIH co-funding), the American Biostasis Foundation STASIS facility ($100K, Comfort Texas), the CPA Repository ($52K), a Space Mice embryo cryopreservation project ($17.5K), the Multi-Organ Cryopreservation HIFU project (€50K), and the CryoDAO Fellowship program ($100-$3,000 micro-grants). Strategic scientific and operational partners include VitaDAO, Tomorrow Bio, Cryopets, European Biostasis Foundation, Oxford Cryotechnology, Advanced Neural Biosciences, and Gaia Life; the co-founder team includes Dr. Emil Kendziorra (CEO of Tomorrow Bio), Kai Micah Mills (Founder & CEO of Cryopets, Thiel Fellow), Eli Mohamad (X-Therma), and Vincent Weisser (co-initiator of VitaDAO & BIO).

CryoDAO does not generate traditional revenue and does not operate a conventional pricing model. Its economic model relies on token-based governance participation, potential returns from IP-NFT commercialization and licensing rights acquired from funded projects (which may flow back to the treasury), and treasury investment management. The Fellowship program is a non-dilutive micro-grant mechanism; the DAO does not take equity or IP in fellowship recipients. Primary stakeholder segments are cryopreservation researchers and scientists, DeFi/crypto community members holding CRYO for governance participation, and longevity and life-extension enthusiasts. Geographic restrictions under Regulation S limit CRYO token holdings by US persons, narrowing the addressable US retail market.

Name

CryoDAO

Legal name

CryoDAO

Website

https://cryodao.org

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

CryoDAO is a Basel-registered decentralized autonomous organization that funds cryopreservation and biostasis research through community governance, serving researchers and longevity-focused crypto community members with a $5M+ treasury across nine funded projects.

Ownership category

akta.pro rank

Product category

Decentralized Science Funding

NAICS

Grantmaking Foundations (813211)

SIC

Finance Services (6199)

akta.pro primary industry

Governance Frameworks & DAO Tooling (modules, templates, standards) (FSAPAHAC)

akta.pro secondary industries

Grants, Funding & Budget Allocation Platforms (FSAPAHAE), DAO Treasury, Governance & On-Chain Finance Tools (FSADAMAL), Cryopreservation, Biobanking & Cell Banking (Cord/Adipose/MSC) (HLAMANAJ)

Keywords

• Decentralized science funding
• Cryopreservation research grants
• DAO governance infrastructure
• Biostasis research platform
• Intellectual property NFTs

Headquarters

HQ city

Cham

HQ country

Switzerland

HQ region

Europe

Offices1 record

Markets served

GTM type

B2C

Offering type

Services

Cost components

Technology or R&D, Operations, Personnel, Marketing or Sales, Others

Revenue model

1. Treasury Investment Returns: In return for funding research, CryoDAO may receive IP/commercialization rights and/or equity. Value created through funded projects flows back into the DAO to fund more research.
2. Token-Based Governance: CRYO token serves as governance token for DAO membership. Value accrues to token holders through successful project outcomes and IP-NFT spinouts.
3. IP-NFT Token Sales: IP-NFT launch generates proceeds through token sales. 50% of funds raised become immediately available for CryoDAO Treasury, the rest funds sub-DAO operating budget.

Pricing tiers

Go-to-market motion1 record

Distribution channels3 records

Marketing channels4 records

Core offering

CryoDAO is a Decentralized Autonomous Organization that funds cryopreservation, biostasis, and cryobiology research through community-governed treasury allocation. It operates the CRYO governance token, an IP-NFT framework that tokenizes intellectual property from funded research for community ownership, and a fellowship program providing micro-grants to researchers. Revenue flows back to the DAO from treasury investment returns and IP/commercialization royalties from funded projects.

Product overview

CryoDAO is a BioDAO (decentralized science organization) pioneering cryopreservation research funding through community governance. The organization operates as a platform combining the CRYO Governance Token (for voting and treasury management) with a Fellowship Program (micro-grants $100-$3,000) to fund cryopreservation projects. CryoDAO has funded multiple research initiatives including molecular profiling for cryoprotectants, whole organ cryopreservation, brain preservation studies, and a cryopreservation facility (STASIS). The platform connects researchers with funding through DAO governance, with over $5M in treasury and 6,000+ community members.

Differentiator

Problem solved

Functional benefit

Products and services

• CRYO Governance Token Token-based governance asset on Ethereum and Base blockchains that grants holders voting rights over CryoDAO treasury allocation and research funding proposals through Snapshot voting.
• CryoDAO Research Funding Platform Platform that channels community-governed treasury capital into cryopreservation, biostasis, and cryobiology research projects through structured grants and IP-NFT backflows.
• CryoDAO Fellowship Program Micro-grant fellowship program providing $100-$3,000 awards to researchers, students, and scientists working in cryopreservation and biostasis fields.
• IP-NFT Framework Framework for tokenizing intellectual property rights from funded research projects into project-specific sub-DAOs, enabling the CryoDAO community to collectively own and benefit from research commercialization.

Quantifiable outcome

• 6+ research projects funded with over $1.5M in total funding allocated

Segments3 records

Ideal customer profiles3 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration3 records

AI capability2 records

Feature2 records

Partnerships

Seven partnerships are on record, tiered core.

• VitaDAOcoreStrategic or Co-development PartnerVitaDAO is a Longevity Research DAO focused on funding longevity research. CryoDAO operates in a complementary space focused on cryopreservation. Both are BioDAOs pioneering decentralized science and share community members and governance principles.
• Tomorrow BiocoreStrategic or Co-development PartnerTomorrow Bio is a cryonics provider partnering on the American Biostasis Foundation (STASIS) project to develop purpose-built long-term cryopreservation facilities. They will store patients at the ABF facility from day one.
• CryopetscoreStrategic or Co-development PartnerCryopets is a cryonics provider for pets. Co-founded by CryoDAO co-founder Kai Micah Mills. Partnering on the STASIS project for cryopreservation facility development and patient storage.
• Advanced Neural BiosciencescoreTechnology or IntegrationAdvanced Neural Biosciences is a cryobiology lab conducting neural cryopreservation research. Led by neuroscientist Chana Phaedra and human cryopreservation expert Aschwin de Wolf. Executing the CRYORAT project (high sub-zero preservation and revival of a rat) for CryoDAO.
• European Biostasis FoundationcoreStrategic or Co-development PartnerEuropean Biostasis Foundation opened the world's first purpose-built long-term cryopreservation facility in Switzerland in 2022. CryoDAO co-founder Dr. Emil Kendziorra is President of the Board. Sharing operational expertise for the STASIS project.
• Oxford CryotechnologycoreTechnology or IntegrationOxford Cryotechnology is a research organization conducting molecular profiling and computational modelling for novel cryoprotectants. Led by Prof. Joao Pedro de Magalhaes and Dr. Roman Bauer. CryoDAO core member Emil Kendziorra is a minority shareholder.
• Gaia LifecoreTechnology or IntegrationGaia Life is a biotechnology company conducting the Live Births from Vitrified and Replanted Whole Ovaries project. Using proprietary nanowarming technology and isochoric preservation. Funding from CryoDAO ($350K) with NIH co-funding for the research.

Scale indicators4 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• Bio.xyz: DeSci DAO launchpad and shared service platform for BioDAOs including CryoDAO. Direct peer providing launch infrastructure and operational tooling for new decentralized science organizations.
• VitaDAO: Longevity research DAO using token-based governance to fund aging and longevity science. Direct peer sharing the same BioDAO/DeSci model, community overlap, and co-founder Vincent Weisser, with a complementary but adjacent research focus.
• Beaker DAO: Decentralized science funding DAO and listed financial partner of CryoDAO. Same DeSci funding model with overlapping community and capital pool for early-stage biotech research.
• HydraDAO: Biostasis-focused DAO co-founded alongside CryoDAO by the same team. Same funding and IP-NFT model, closely overlapping mission in human preservation research.
• ResearchHub: Decentralized platform for scientific research collaboration and peer review using token incentives. Direct peer in the DeSci ecosystem addressing a different stage of the research lifecycle but with comparable community-governance funding model.
• Molecule: DeSci platform providing IP-NFT infrastructure for tokenizing biopharma intellectual property. Direct infrastructure peer — CryoDAO's IP-NFT framework is built on Molecule's tooling and Program Manager Leonard Boltz supports both organizations.

Broad incumbents

• 21st Century Medicine: Cryobiology research company led by Dr. Gregory Fahy, scientific advisor to CryoDAO. Broad incumbent in cryoprotectant science and vitrification research, providing a traditional commercial contrast to CryoDAO's DAO model.
• Cryopets: Pet cryopreservation provider founded by CryoDAO co-founder Kai Micah Mills. Broad incumbent operating at the commercial endpoint of the cryopreservation value chain with direct strategic alignment via co-founder overlap.
• Tomorrow Bio: Cryonics provider offering human cryopreservation services in Europe. Broad incumbent in the cryopreservation value chain — strategic partner on the STASIS facility, led by CryoDAO co-founder Dr. Emil Kendziorra.
• Alcor Life Extension Foundation: Established US-based cryonics non-profit founded in 1972. Broad incumbent in cryopreservation services and biostasis research funding, with longer operational track record but more centralized governance model.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

• Xx.com/cryodao

Compliance2 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles15 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about CryoDAO